# Multicenter Trial of Immunotherapy With House Dust Mite Allergoid

> **NCT00540631** · PHASE3 · COMPLETED · sponsor: **Allergopharma GmbH & Co. KG** · enrollment: 108 (actual)

## Conditions studied

- Rhinoconjunctivitis

## Interventions

- **BIOLOGICAL:** specific immunotherapy with Acaroid, subcutaneously, Up-titration till strength B 0.6 mL (6000 TU)

## Key facts

- **NCT ID:** NCT00540631
- **Lead sponsor:** Allergopharma GmbH & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-08
- **Final completion:** 2011-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540631, "Multicenter Trial of Immunotherapy With House Dust Mite Allergoid". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00540631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*